NeuroMetrix (NASDAQ:NURO) Shares Up 9.1%

Shares of NeuroMetrix, Inc. (NASDAQ:NURO) shot up 9.1% during mid-day trading on Wednesday . The stock traded as high as $3.40 and last traded at $3.36. 579,157 shares traded hands during mid-day trading, an increase of 70% from the average session volume of 339,882 shares. The stock had previously closed at $3.08.

The firm’s 50 day moving average is $2.75 and its 200-day moving average is $2.05.

NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings data on Thursday, October 22nd. The medical device company reported ($0.07) earnings per share (EPS) for the quarter. NeuroMetrix had a negative net margin of 38.80% and a negative return on equity of 71.00%. The business had revenue of $2.04 million during the quarter.

A hedge fund recently raised its stake in NeuroMetrix stock. Wedbush Securities Inc. grew its stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO) by 69.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 34,841 shares of the medical device company’s stock after buying an additional 14,245 shares during the period. Wedbush Securities Inc. owned 0.92% of NeuroMetrix worth $59,000 at the end of the most recent reporting period. 1.49% of the stock is currently owned by institutional investors.

NeuroMetrix Company Profile (NASDAQ:NURO)

NeuroMetrix, Inc, a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes.

Featured Story: Trading Ex-Dividend